Search Browse Earnings

PMV Pharmaceuticals, Inc.

Nasdaq:PMVP

Pharmaceutical Preparations·PRINCETON, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

PMV Pharmaceuticals, Inc. — SlamSEC

Revenue

—

Adj. EBITDA

-$78.9M

FY 2025

Net Income

-$69.0M

FY 2025

EPS (Diluted)

-$1.44

FY 2025

Stock Price

$1.63

+6.9%

2026-03-06

52W Range

$0.81 – $1.88

P/E Ratio

-1.1x

Market Cap

$86.9M

Cash

$40.9M

FY 2025

Total Debt

—

Net Cash

$40.9M

Enterprise Value

$46.1M

Debt / EBITDA

0.5x

FY 2025

EV / EBITDA

-0.6x

Employees

—